European Pharmaceutical Review provides insights and information related to the pharmaceutical industry. It self-described as a resource for professionals in the sector.

European Pharmaceutical Review

GlobalData Plc provides business information in the form of proprietary data, analytics, and insights in Europe, North America, and the Asia Pacific. The company offers performance advertising services. It serves aerospace, defense, and security; apparel; automotive; banking and payments; construction; consumer; foodservices; healthcare; insurance; medical devices; mining; oil and gas; packaging; pharmaceutical; power; retail; technology; travel and tourism; and sport industries, as well as public sectors. The company was formerly known as Progressive Digital Media Group Plc and changed its name to GlobalData Plc in January 2016. GlobalData Plc was incorporated in 2000 and is headquartered in London, the United Kingdom.

Mike Danson

GlobalData Plc

Pharma Now is a monthly B2B magazine that covers trends, technological innovations, and insights in the pharmaceutical and biopharmaceutical sectors. It provides industry news and updates, interviews with leaders, market insights, and regulatory updates.

Metric
Company Name	European Pharmaceutical Review	GlobalData Plc	Pharma Now
Symbol		DATA
MSH ID	COM:EUROPEANPHARMACEUTICALREVIEW	COM:GLOBALDATA	LIVE:PHARMANOW
Market	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Industrials	Consumer Services
Industry	Pharmaceuticals	Consulting Services	Pharmaceuticals
Country	GB	GB	IN
Stage
Employee Count		3.53K
Website	europeanpharmaceuticalreview.com	globaldata.com	pharmanow.live
LinkedIn			pharma-now
Founders

Metric
Market Cap		20.05M
Enterprise Value
Monthly Web Traffic		18.54M
Web Traffic Growth		-0.10
Valuation
Raised Capital

Metric
Revenue		347.99M
Revenue (LTM)
Revenue (NTM)
Gross Profit		158.39M
EBITDA		112.64M
Operating Income		91.23M
Net Income		39.25M
EPS		0.05
Diluted EPS		0.05
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.47
Operating Profit Margin		0.29
EBITDA Margin		0.32
Net Profit Margin		0.12
Return on Equity		0.53
Return on Assets		0.06
Return on Capital Employed		0.21

COM:EUROPEANPHARMACEUTICALREVIEW

European Pharmaceutical Review

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		7.39
P/B Ratio		4.67
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		6.80
EV Multiple		21.36

Metric
Days Sales Outstanding
Days Payables Outstanding		32.52
Days Inventory Outstanding		0.00
Operating Cycle		92.49
Cash Conversion Cycle		13.01
Asset Turnover		0.55

Metric
Operating Cash Flow		83.84M
Free Cash Flow		78.49M
Cash Flow to Debt		17.44
Operating Cash Flow/Sales		0.24
Free Cash Flow Yield		0.04

Metric
Cash & Equivalents		25.23M
Accounts Receivable		-8.28M
Inventory
Goodwill		396.41M
Debt to Capitalization		0.82
Debt to Assets		0.61
Current Ratio		0.67
Quick Ratio		1.25

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue
SG&A to Revenue		0.25